Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Net Margin (2017 - 2026)

Updated

Moderna (MRNA) posted Net Margin of -539.31% for Q2 2026, up 41.68 percentage points from -580.99% a year earlier but down 194.07 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Net Margin (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Moderna was -141.43%, down 47.11 percentage points year-over-year; for FY2025, it came in at -145.16%, down 35.12 percentage points from FY2024.

  • Annual Net Margin has declined for four consecutive years, with a five-year change of -52.13 percentage points (FY2020 to FY2025).
  • In prior years, Moderna's Net Margin was -110.04% in FY2024 (-41.21 pp), -68.84% in FY2023 (-112.25 pp), 43.41% in FY2022 (-22.65 pp) and 66.06% in FY2021 (+159.09 pp).
  • Quarterly Net Margin has run from a low of -899.07% in Q1 2025 to a high of 67.51% in Q4 2021 over five years.
  • On a year-over-year basis, Net Margin increased in three of the last eight quarters, with an average year-over-year change of +49.85 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q1 2026, with a gain of 553.83 percentage points; the weakest was Q1 2024, with a drop of 707.84 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -345.24% (Q1 2026), -121.83% (Q4 2025) and -19.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 21.86%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 21.27%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -8.04%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 22.65%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 16.30%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -134.51%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -1.65%
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn -539.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -539.31%
Mar 31, 2026 -345.24%
Dec 31, 2025 -121.83%
Sep 30, 2025 -19.69%
Jun 30, 2025 -580.99%
Mar 31, 2025 -899.07%
Dec 31, 2024 -115.94%
Sep 30, 2024 0.70%
Jun 30, 2024 -530.71%
Mar 31, 2024 -703.59%
Dec 31, 2023 7.72%
Sep 30, 2023 -198.25%
Jun 30, 2023 -401.16%
Mar 31, 2023 4.24%
Dec 31, 2022 28.82%
Sep 30, 2022 31.00%
Jun 30, 2022 46.26%
Mar 31, 2022 60.29%
Dec 31, 2021 67.51%
Sep 30, 2021 67.08%
API Access

Moderna Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=MRNA&period=max&api_key=YOUR_API_KEY